Table 3 Characteristics of the RCVS patients
Vascular wall enhancement | p | ||
|---|---|---|---|
Absence (n = 26) | Presence (n = 22) | ||
Sex (female), n (%) | 23 (88.5%) | 19 (86.4%) | 1.00 |
Age (years), man ± SD | 49.7 ± 11.1 | 52.3 ± 7.5 | 0.53 |
Time to MRI from onset (days), mean ± SD | 11.8 ± 6.9 | 12.0 ± 7.6 | 0.93 |
Vascular risk factors, n (%) | |||
Hypertension | 2 (7.7%) | 2 (9.1%) | 0.86 |
Diabetes | 1 (3.8%) | 2 (9.1%) | 0.59 |
CAD | 0 (0.0%) | 0 (0.0%) | NA |
Headache attacks, n (%) | |||
Number of total attacks | 8.4 ± 8.4 | 4.7 ± 4.4 | 0.04 |
Duration of whole course (d) | 10.5 ± 6.3 | 8.8 ± 5.1 | 0.32 |
Frequency (number/duration) | 0.9 ± 1.0 | 0.6 ± 0.3 | 0.07 |
Triggers, n (%) | |||
Bathing | 8 (30.8%) | 5 (22.7%) | 0.53 |
Exertion | 2 (7.7%) | 3 (13.6%) | 0.65 |
Cough | 2 (7.7%) | 1 (4.5%) | 1.00 |
Defecation | 7 (26.9%) | 11 (50.0%) | 0.10 |
Emotion | 6 (23.1%) | 4 (18.2%) | 0.68 |
Sex | 5 (19.2%) | 4 (18.2%) | 1.00 |
Mean number of triggers per patient | 1.4 ± 0.9 | 1.6 ± 1.2 | 0.65 |
Mean total WMH volume (ml) | 1.1 ± 1.2 | 1.3 ± 1.8 | 0.71 |